Human Alpha-1-Antitrypsin (hAAT) therapy reduces renal dysfunction and acute tubular necrosis in a murine model of bilateral kidney ischemia-reperfusion injury
Nuria Maicas, Johan van der Vlag, Janin Bublitz, Sandrine Florquin, Marinka Bakker-van Bebber, Charles A Dinarello, Vivienne Verweij, Roos Masereeuw, Leo A Joosten, Luuk B Hilbrands
Research output: Contribution to journal › Article › Academic › peer-review
Fingerprint
Dive into the research topics of 'Human Alpha-1-Antitrypsin (hAAT) therapy reduces renal dysfunction and acute tubular necrosis in a murine model of bilateral kidney ischemia-reperfusion injury'. Together they form a unique fingerprint.